Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan.

Shigeaki Suzuki Akiyuki Uzawa Yuriko Nagane Masayuki Masuda Shingo Konno Tomoya Kubota Makoto Samukawa Kei Ishizuchi Daiki Tokuyasu Hideo Handa Manato Yasuda Naoki Kawaguchi Takashi Kimura Yasushi Suzuki Takamichi Sugimoto Naoya Minami Masanori P Takahashi Hiroyuki Murai Kimiaki Utsugisawa

Published in: Neurology. Clinical practice (2024)

Efgartigimod can be considered for the treatment of patients with generalized MG who do not achieve minimal manifestations, with a broad flexibility of patient selection and treatment schedules.

Keyphrases

smoking cessation